About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Arizona | 705 Studies

Clinical Trials Breast CancerArizona

Breast Cancer Clinical Trials in Arizona

Find 705 clinical trials for breast cancer near Arizona. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 705 trials

Active not recruitingCompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted TherapyThis trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast…NCT04266249·Birmingham, Alabama and 1007 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedOral AMXT 1501 Dicaprate in Combination With IV DFMOA Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patients.NCT05500508·Phoenix, Arizona and 6 others

CompletedTVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast CancerThis phase II trial studies how well FASN inhibitor TVB-2640, paclitaxel, and trastuzumab work in treating patients with HER2 positive breast cancer that has spread to other…NCT03179904·Scottsdale, Arizona and 2 others

TerminatedPRO1107 in Patients With Advanced Solid TumorsThis is a global, open-label, multicenter Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics (PK), and antitumor activity of GEN1107 (PRO1107) in participants…NCT06171789·Scottsdale, Arizona and 6 others

CompletedStudy of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenRATIONALE: Estrogen can stimulate the growth of breast cancer cells.NCT00003906·Huntsville, Alabama and 515 others

CompletedS0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerRATIONALE: Cholecalciferol may prevent breast cancer in premenopausal women.NCT01097278·Anniston, Alabama and 359 others

TerminatedTesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCCONTESSA is a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with HER2 negative, HR positive LA/MBC previously treated with a taxane in the…NCT03326674·Chandler, Arizona and 206 others

Active not recruitingA Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerThe main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy, and how well imlunestrant with abemaciclib work compared to…NCT04975308·Chandler, Arizona and 242 others

CompletedMarimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following ChemotherapyRATIONALE: Marimastat may stop the growth of breast cancer by stopping blood flow to the tumor.NCT00003010·Scottsdale, Arizona and 24 others

CompletedSuppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerRATIONALE: Estrogen can stimulate the growth of breast tumor cells.NCT00066690·Birmingham, Alabama and 499 others

TerminatedPF-06952229 Treatment in Adult Patients With Advanced Solid TumorsA Phase 1 dose escalation and expansion study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors.NCT03685591·Scottsdale, Arizona and 14 others

CompletedAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)This pilot, non-interventional, observational, Web-based, prospective cohort study is designed to collect self-reported safety and effectiveness and genetic data from subjects…NCT01598597·Many Locations, Alabama and 49 others

UnknownA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsThis proposed Phase I clinical trial of SON-DP is an FIH, open-label, Phase Ia/Ib dose escalation and expansion study to evaluate the safety, tolerability, PK, and PD of SON-DP in…NCT05989724·Gilbert, Arizona and 4 others

CompletedA Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has SpreadThe main purpose of this study is to evaluate whether the study drug known as abemaciclib is effective in treating participants with breast cancer who have already tried other…NCT02102490·Sedona, Arizona and 35 others

TerminatedCapecitabine With Digoxin for Metastatic Breast CancerTo evaluate the Growth Modulation Index (GMI) of the combination of metronomic capecitabine with oral digoxin in metastatic breast cancerNCT01887288·Goodyear, Arizona

CompletedSafety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal WomenThis study is a randomized, double-blind, placebo-controlled, adaptive design, multi-center study of the long-term cardiovascular and breast safety of LibiGel in the treatment of…NCT00612742·Birmingham, Alabama and 148 others

CompletedImpact of Osteopathic Manipulative Medicine on Sentinal Lymph Node Biopsy Dye and Tracer UptakeThe goal of this clinical trial is to learn if osteopathic manipulative medicine (OMM) will allow for more uptake of isosulfan blue dye and radiotracers used in sentinal lymph…NCT07269860·Tucson, Arizona

CompletedA Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast CancerThis is a randomized, double-blind, placebo-controlled, multicenter, pre-operative Phase II study designed to estimate the efficacy of ipatasertib combined with paclitaxel…NCT02301988·Tucson, Arizona and 41 others

CompletedTrial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)The primary objective of this study is to compare the efficacy of sacituzumab govitecan to the treatment of physician's choice (TPC) as measured by independently-reviewed…NCT02574455·Daphne, Alabama and 229 others

RecruitingA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyThis is a global extension study to provide continued access to niraparib and further characterize the long-term safety of niraparib treatment in participants who are currently…NCT04641247·Tucson, Arizona and 24 others

Page 1 of 36Next

Other Conditions in Arizona

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma